Cesar Aliaga

Cesar Aliaga is a Senior Research Associate in the Department of Molecular and Precision Medicine, with extensive contributions to carcinogenesis research, pharmacology, and microbiome studies. His work spans environmental and tobacco carcinogens, cancer prevention strategies, and microbiome-immunity interactions.

• Primary Affiliation: Department of Molecular and Precision Medicine

Research Interests: Focus on carcinogenesis, oral cancer, microbiome modulation, and metabolic reprogramming, particularly in the context of environmental and tobacco carcinogens. His studies explore dietary interventions (e.g., black raspberry, quercetin) and synthetic compounds (e.g., antioxidant precursors, Se-NSAIDs) for cancer prevention and treatment.

Recent Trends: Publications emphasize dibenzo[a,l]pyrene and chrysene carcinogens, oral and cecal microbiome alterations, and genomic instability in HPV-transformed cells. Collaborations include experts in cancer biology, virology, and nutritional science.

Scientific Output: Over 55 research outputs since 1994, with 2025 publications focusing on microbiome-cancer interactions and HPV-related genomic changes. His work aligns with UN Sustainable Development Goals for health and well-being.